Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy

References

• American Diabetes A. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46. doi:10.2337/dc12-2625. PMID:23468086.
   PubMed Web of Science ®Google Scholar
• Sadosky A, Mardekian J, Parsons B, Hopps M, Bienen EJ, Markman J. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy. J Diabetes Complications. 2015;29:212–7. doi:10.1016/j.jdiacomp.2014.10.013. PMID:25498300.
   PubMed Web of Science ®Google Scholar
• Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract (1995). 1998;33:95–8, 101– 4, 7–10 passim. doi:10.3810/hp.1998.10.114.
   PubMed Web of Science ®Google Scholar
• Feldman EL, Nave KA, Jensen TS, Bennett DL. New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain. Neuron. 2017;93:1296–313. doi:10.1016/j.neuron.2017.02.005. PMID:28334605.
   PubMed Web of Science ®Google Scholar
• Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18:343–9. doi:10.1097/00002508-200211000-00001. PMID:12441827.
   PubMed Web of Science ®Google Scholar
• Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep. 2012;16:191–8. doi:10.1007/s11916-012-0256-0. PMID:22395856.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Wollan PC, Weingarten TN, Watson JC, Hooten WM, Melton LJ, 3rd. The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population. Pain Med. 2009;10:586–93. doi:10.1111/j.1526-4637.2009.00588.x. PMID:20849570.
   PubMed Web of Science ®Google Scholar
• Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26:1790–5. doi:10.2337/diacare.26.6.1790. PMID:12766111.
   PubMed Web of Science ®Google Scholar
• Argoff CE, Cole BE, Fishbain DA, Irving GA. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc. 2006;81:S3–11. doi:10.1016/S0025-6196(11)61474-2. PMID:16608048.
   PubMed Web of Science ®Google Scholar
• Frenzen PD. Economic cost of Guillain-Barre syndrome in the United States. Neurology. 2008;71:21–7. doi:10.1212/01.wnl.0000316393.54258.d1. PMID:18591502.
   PubMed Web of Science ®Google Scholar
• Watson JC, Dyck PJ. Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. Mayo Clin Proc. 2015;90:940–51. doi:10.1016/j.mayocp.2015.05.004. PMID:26141332.
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Price RS, Feldman EL. Distal Symmetric Polyneuropathy: A Review. JAMA. 2015;314:2172–81. doi:10.1001/jama.2015.13611. PMID:26599185.
   PubMed Web of Science ®Google Scholar
• Noble J, Munro CA, Prasad VS, Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J Trauma. 1998;45:116–22. doi:10.1097/00005373-199807000-00025. PMID:9680023.
   PubMed Web of Science ®Google Scholar
• Palispis WA, Gupta R. Surgical repair in humans after traumatic nerve injury provides limited functional neural regeneration in adults. Exp Neurol. 2017;290:106–14. doi:10.1016/j.expneurol.2017.01.009. PMID:28111229.
   PubMed Web of Science ®Google Scholar
• Grinsell D, Keating CP. Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies. Biomed Res Int. 2014;2014:698256. doi:10.1155/2014/698256. PMID:25276813.
   PubMed Web of Science ®Google Scholar
• Bär KJ, Saldanha GJ, Kennedy AJ, Facer P, Birch R, Carlstedt T, Anand P. GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia. Neuroreport. 1998;9:43–7. doi:10.1097/00001756-199801050-00009. PMID:9592045.
   PubMed Web of Science ®Google Scholar
• Bennett DL, Michael GJ, Ramachandran N, Munson JB, Averill S, Yan Q, McMahon SB, Priestley JV. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci. 1998;18:3059–72. doi:10.1523/JNEUROSCI.18-08-03059.1998. PMID:9526023.
   PubMed Web of Science ®Google Scholar
• Hammarberg H, Piehl F, Cullheim S, Fjell J, Hökfelt T, Fried K. GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury. Neuroreport. 1996;7:857–60. doi:10.1097/00001756-199603220-00004. PMID:8724660.
   PubMed Web of Science ®Google Scholar
• Naveilhan P, ElShamy WM, Ernfors P. Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. Eur J Neurosci. 1997;9:1450–60. doi:10.1111/j.1460-9568.1997.tb01499.x. PMID:9240402.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Chai YF, Cao L, Lu CL, He C. Glial cell line-derived neurotrophic factor enhances axonal regeneration following sciatic nerve transection in adult rats. Brain Res. 2001;902:272–6. doi:10.1016/S0006-8993(01)02395-2. PMID:11384621.
   PubMed Web of Science ®Google Scholar
• Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibáñez CF. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol. 1995;130:137–48. doi:10.1083/jcb.130.1.137. PMID:7790368.
   PubMed Web of Science ®Google Scholar
• Magill CK, Tuffaha SH, Yee A, Luciano JP, Hunter DA, Mackinnon SE, Borschel GH. The short- and long-term effects of Seprafilm on peripheral nerves: a histological and functional study. J Reconstr Microsurg. 2009;25:345–54. doi:10.1055/s-0029-1215526. PMID:19396746.
   PubMed Web of Science ®Google Scholar
• Tannemaat MR, Eggers R, Hendriks WT, de Ruiter GC, van Heerikhuize JJ, Pool CW, Malessy MJ, Boer GJ, Verhaagen J. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur J Neurosci. 2008;28:1467–79. doi:10.1111/j.1460-9568.2008.06452.x. PMID:18973572.
   PubMed Web of Science ®Google Scholar
• Jubran M, Widenfalk J. Repair of peripheral nerve transections with fibrin sealant containing neurotrophic factors. Exp Neurol. 2003;181:204–12. doi:10.1016/S0014-4886(03)00041-4. PMID:12781993.
   PubMed Web of Science ®Google Scholar
• Hoke A, Cheng C, Zochodne DW. Expression of glial cell line-derived neurotrophic factor family of growth factors in peripheral nerve injury in rats. Neuroreport. 2000;11:1651–4. doi:10.1097/00001756-200006050-00011. PMID:10852218.
   PubMed Web of Science ®Google Scholar
• Xu P, Rosen KM, Hedstrom K, Rey O, Guha S, Hart C, Corfas G. Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway. Glia. 2013;61:1029–40. doi:10.1002/glia.22491. PMID:23553603.
   PubMed Web of Science ®Google Scholar
• Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 1995;373:339–41. doi:10.1038/373339a0. PMID:7830767.
   PubMed Web of Science ®Google Scholar
• Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen RA, Simpson LC corrected to Simmons L, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 1994;266:1062–4. doi:10.1126/science.7973664. PMID:7973664.
   PubMed Web of Science ®Google Scholar
• Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 2001;12:361–73. doi:10.1016/S1359-6101(01)00012-0. PMID:11544105.
   PubMed Web of Science ®Google Scholar
• Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci. 2002;3:383–94. doi:10.1038/nrn812. PMID:11988777.
   PubMed Web of Science ®Google Scholar
• Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 1996;85:1113–24. doi:10.1016/S0092-8674(00)81311-2. PMID:8674117.
   PubMed Web of Science ®Google Scholar
• Ibanez CF. Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol. 2017;18:477–494. doi:10.1101/cshperspect.a009134. PMID:23378586.
   PubMedGoogle Scholar
• Ibanez CF, Andressoo JO. Biology of GDNF and its receptors – Relevance for disorders of the central nervous system. Neurobiol Dis. 2017;97:80–9. doi:10.1016/j.nbd.2016.01.021. PMID:26829643.
   PubMed Web of Science ®Google Scholar
• Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013;138:155–75. doi:10.1016/j.pharmthera.2013.01.004. PMID:23348013.
   PubMed Web of Science ®Google Scholar
• Natsume A, Wolfe D, Hu J, Huang S, Puskovic V, Glorioso JC, Fink DJ, Mata M. Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer. Exp Neurol. 2003;184:878–86. doi:10.1016/S0014-4886(03)00334-0. PMID:14769380.
   PubMed Web of Science ®Google Scholar
• Marconi S, Castiglione G, Turano E, Bissolotti G, Angiari S, Farinazzo A, Constantin G, Bedogni G, Bedogni A, Bonetti B. Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng Part A. 2012;18:1264–72. doi:10.1089/ten.tea.2011.0491. PMID:22332955.
   PubMed Web of Science ®Google Scholar
• Hoke A, Gordon T, Zochodne DW, Sulaiman OA. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol. 2002;173:77–85. doi:10.1006/exnr.2001.7826. PMID:11771940.
   PubMed Web of Science ®Google Scholar
• Mizisin AP, Weerasuriya A. Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta neuropathologica. 2011;121:291–312. doi:10.1007/s00401-010-0783-x. PMID:21136068.
   PubMed Web of Science ®Google Scholar
• Reina MA, Lopez A, Villanueva MC, de Andres JA, Leon GI. [Morphology of peripheral nerves, their sheaths, and their vascularization]. Rev Esp Anestesiol Reanim. 2000;47:464–75. PMID:11171467.
   PubMedGoogle Scholar
• Reina MA, Lopez A, Villanueva MC, De Andres JA, Maches F. [The blood-nerve barrier in peripheral nerves]. Rev Esp Anestesiol Reanim. 2003;50:80–6. PMID:12712870.
   PubMedGoogle Scholar
• Ubogu EE. The molecular and biophysical characterization of the human blood-nerve barrier: current concepts. J Vasc Res. 2013;50:289–303. doi:10.1159/000353293. PMID:23839247.
   PubMed Web of Science ®Google Scholar
• Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circulation Res. 2007;100:158–73. doi:10.1161/01.RES.0000255691.76142.4a. PMID:17272818.
   PubMed Web of Science ®Google Scholar
• Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circulation res. 2007;100:174–90. doi:10.1161/01.RES.0000255690.03436.ae. PMID:17272819.
   PubMed Web of Science ®Google Scholar
• Yano K, Gale D, Massberg S, Cheruvu PK, Monahan-Earley R, Morgan ES, Haig D, von Andrian UH, Dvorak AM, Aird WC. Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood. 2007;109:613–5. doi:10.1182/blood-2006-05-026401. PMID:16990601.
   PubMed Web of Science ®Google Scholar
• Potente M, Makinen T. Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol. 2017. doi:10.1038/nrm.2017.36. PMID:28537573.
   PubMed Web of Science ®Google Scholar
• Reddy CL, Yosef N, Ubogu EE. VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro. Cellular Mol Neurobiol. 2013;33:789–801. doi:10.1007/s10571-013-9946-3.
   PubMed Web of Science ®Google Scholar
• Yosef N, Ubogu EE. GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization. Microvasc Res. 2012;83:298–310. doi:10.1016/j.mvr.2012.01.005. PMID:22326552.
   PubMed Web of Science ®Google Scholar
• Palladino SP, Helton ES, Jain P, Dong C, Crowley MR, Crossman DK, Ubogu EE. The Human Blood-Nerve Barrier Transcriptome. Sci Rep. 2017;7:17477. doi:10.1038/s41598-017-17475-y. PMID:29234067.
   PubMed Web of Science ®Google Scholar
• Shimizu F, Sano Y, Saito K, Abe MA, Maeda T, Haruki H, Kanda T. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res. 2012;37:401–9. doi:10.1007/s11064-011-0626-8. PMID:22002662.
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Chiba H, Utsumi H, Miyajima H, Ishizaki T, Gotoh T, Kuwahara K, Tobioka H, Satoh M, Mori M, et al. Expression of receptors for glial cell line-derived neurotrophic factor (GDNF) and neurturin in the inner blood-retinal barrier of rats. Cell Struct Funct. 2000;25:237–41. doi:10.1247/csf.25.237. PMID:11129793.
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Utsumi H, Chiba H, Yamada-Sasamori Y, Tobioka H, Kamimura Y, Furuuchi K, Kokai Y, Nakagawa T, Mori M, et al. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Communications. 1999;261:108–12. doi:10.1006/bbrc.1999.0992.
   PubMed Web of Science ®Google Scholar
• Kamimura Y, Chiba H, Utsumi H, Gotoh T, Tobioka H, Sawada N. Barrier function of microvessels and roles of glial cell line-derived neurotrophic factor in the rat testis. Med Electron Microsc. 2002;35:139–45. doi:10.1007/s007950200017. PMID:12353134.
   PubMedGoogle Scholar
• Meir M, Flemming S, Burkard N, Bergauer L, Metzger M, Germer CT, Schlegel N. Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2015;309:G613–24. doi:10.1152/ajpgi.00357.2014. PMID:26294673.
   PubMed Web of Science ®Google Scholar
• Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C, Banzato S, Grillo AR, Spagnol L, De Caro R, et al. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology. 2013;145:1323–33. doi:10.1053/j.gastro.2013.08.047. PMID:23994200.
   PubMed Web of Science ®Google Scholar
• Steinkamp M, Geerling I, Seufferlein T, von Boyen G, Egger B, Grossmann J, Ludwig L, Adler G, Reinshagen M. Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology. 2003;124:1748–57. doi:10.1016/S0016-5085(03)00404-9. PMID:12806607.
   PubMed Web of Science ®Google Scholar
• Meir M, Flemming S, Burkard N, Wagner J, Germer CT, Schlegel N. The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function in health and disease. Am J Physiol Gastrointest Liver Physiol. 2016;310:G1118–23. doi:10.1152/ajpgi.00125.2016. PMID:27151942.
   PubMed Web of Science ®Google Scholar
• Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gomez-Diaz R, Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci. 2008;11:755–61. doi:10.1038/nn.2136. PMID:18536709.
   PubMed Web of Science ®Google Scholar
• Bridge PM, Ball DJ, Mackinnon SE, Nakao Y, Brandt K, Hunter DA, Hertl C. Nerve crush injuries–a model for axonotmesis. Exp Neurol. 1994;127:284–90. doi:10.1006/exnr.1994.1104. PMID:8033968.
   PubMed Web of Science ®Google Scholar
• Ueno M, Sakamoto H, Kanenishi K, Onodera M, Akiguchi I, Hosokawa M. Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). Neurobiol Aging. 2001;22:469–78. doi:10.1016/S0197-4580(01)00213-5. PMID:11378254.
   PubMed Web of Science ®Google Scholar
• Hashizume K, Black KL. Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. J Neuropathol Exp Neurol. 2002;61:725–35. doi:10.1093/jnen/61.8.725. PMID:12152787.
   PubMed Web of Science ®Google Scholar
• Martins T, Burgoyne T, Kenny BA, Hudson N, Futter CE, Ambrosio AF, Silva AP, Greenwood J, Turowski P. Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology. 2013;65:74–82. doi:10.1016/j.neuropharm.2012.08.021. PMID:22960442.
   PubMed Web of Science ®Google Scholar
• Ubogu EE. Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention. Acta Neuropathol. 2015;130:445–68. doi:10.1007/s00401-015-1466-4. PMID:26264608.
   PubMed Web of Science ®Google Scholar
• Xia RH, Yosef N, Ubogu EE. Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barre syndrome. J Neuroimmunol. 2010;219:54–63. doi:10.1016/j.jneuroim.2009.11.019. PMID:20034679.
   PubMed Web of Science ®Google Scholar
• Ubogu EE. Translational strategies in peripheral neuroinflammation and neurovascular repair. Transl Neurosci. 2012;3:373–83. doi:10.2478/s13380-012-0039-4. PMID:23638307.
   PubMed Web of Science ®Google Scholar
• Peltonen S, Alanne M, Peltonen J. Barriers of the peripheral nerve. Tissue Barriers. 2013;1:e24956. doi:10.4161/tisb.24956. PMID:24665400.
   PubMedGoogle Scholar
• Mukhamedshina YO, Gilazieva ZE, Arkhipova SS, Galieva LR, Garanina EE, Shulman AA, Yafarova GG, Chelyshev YA, Shamsutdinova NV, Rizvanov AA. Electrophysiological, Morphological, and Ultrastructural Features of the Injured Spinal Cord Tissue after Transplantation of Human Umbilical Cord Blood Mononuclear Cells Genetically Modified with the VEGF and GDNF Genes. Neural Plast. 2017;2017:9857918. doi:10.1155/2017/9857918. PMID:28421147.
   PubMedGoogle Scholar
• Yuan F, Yosef N, Lakshmana Reddy C, Huang A, Chiang SC, Tithi HR, Ubogu EE. CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barre syndrome. PLoS One. 2014;9:e90463. doi:10.1371/journal.pone.0090463. PMID:24632828.
   PubMed Web of Science ®Google Scholar
• Xia RH, Yosef N, Ubogu EE. Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barre syndrome. Neuropathol Appl Neurobiol. 2010;36:388–98. doi:10.1111/j.1365-2990.2010.01092.x. PMID:20500551.
   PubMed Web of Science ®Google Scholar
• Smith CE, Atchabahian A, Mackinnon SE, Hunter DA. Development of the blood-nerve barrier in neonatal rats. Microsurgery. 2001;21:290–7. doi:10.1002/micr.1055. PMID:11754428.
   PubMed Web of Science ®Google Scholar
• Kaya M, Ahishali B. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase. Methods Mol Biol. 2011;763:369–82. doi:10.1007/978-1-61779-191-8_25. PMID:21874465.
   PubMedGoogle Scholar
• Nico B, Frigeri A, Nicchia GP, Corsi P, Ribatti D, Quondamatteo F, Herken R, Girolamo F, Marzullo A, Svelto M, et al. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia. 2003;42:235–51. doi:10.1002/glia.10216. PMID:12673830.
   PubMed Web of Science ®Google Scholar
• Ma N, Hunt NH, Madigan MC, Chan-Ling T. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol. 1996;149:1745–62. PMID:8909263.
   PubMed Web of Science ®Google Scholar
• Saadoun S, Tait MJ, Reza A, Davies DC, Bell BA, Verkman AS, Papadopoulos MC. AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology. Neuroscience. 2009;161:764–72. doi:10.1016/j.neuroscience.2009.03.069. PMID:19345723.
   PubMed Web of Science ®Google Scholar
• Dong C, Greathouse KM, Beacham RL, Palladino SP, Helton ES, Ubogu EE. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy. Exp Neurol. 2017;292:35–45. doi:10.1016/j.expneurol.2017.02.012. PMID:28215575.
   PubMed Web of Science ®Google Scholar
• Dong C, Palladino SP, Helton ES, Ubogu EE. The pathogenic relevance of alphaM-integrin in Guillain-Barre syndrome. Acta Neuropathol. 2016;132:739–52. doi:10.1007/s00401-016-1599-0. PMID:27460017.
   PubMed Web of Science ®Google Scholar
• Ubogu EE, Yosef N, Xia RH, Sheikh KA. Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model. J Peripheral Nervous System. 2012;17:53–61. doi:10.1111/j.1529-8027.2012.00375.x.
   PubMed Web of Science ®Google Scholar